A small amount of fat does not affect piperaquine exposure in patients with malaria.

A small amount of fat does not affect piperaquine exposure in patients with malaria.

Diğer sürümleri göster (1)

Dihydroartemisinin-piperaquine is a new, highly effective, and well-tolerated combination treatment for uncomplicated falciparum malaria. The lipophilic characteristic of piperaquine suggests that administration together with fat will increase the oral bioavailability of the drug, and this has been...

Detaylı Bibliyografya
Asıl Yazarlar:	Annerberg, A, Lwin, K, Lindegardh, N, Khrutsawadchai, S, Ashley, E, Day, N, Singhasivanon, P, Tarning, J, White, N, Nosten, F
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

A small amount of fat does not affect piperaquine exposure in patients with malaria.
Yazar:: Annerberg, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
Yazar:: Ashley, E, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
Yazar:: Ashley, E, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Pitfalls in estimating piperaquine elimination.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Yazar:: Lwin, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
Yazar:: Lwin, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
Yazar:: Phyo, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
Yazar:: Bergstrand, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
Yazar:: Lindegardh, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
Yazar:: Adam, I, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
Yazar:: Zongo, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
Yazar:: Adam, I, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Yazar:: Hoglund, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Quantification of the antimalarial piperaquine in plasma.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
Yazar:: Lwin, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
Yazar:: Mytton, O, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Characterization of human urinary metabolites of the antimalarial piperaquine.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Efficacy and safety of dihydroartemisinin-piperaquine.
Yazar:: Myint, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
Yazar:: Issaka Zongo, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
Yazar:: Hoglund Richard M, ve diğerleri
Baskı/Yayın Bilgisi: (2012-11-01)

How much fat is necessary to optimize lumefantrine oral bioavailability?
Yazar:: Ashley, E, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Yazar:: Smithuis, F, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
Yazar:: Hoglund, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
Yazar:: Awab, G, ve diğerleri
Baskı/Yayın Bilgisi: (2010)